Description du projet
Une plateforme de santé en ligne pour le diagnostic et la thérapie des maladies gastro-intestinales
Le projet eCAP, financé par l’UE, a pour ambition de créer un dispositif médical innovant combinant une capsule intelligente et une plateforme de santé en ligne pour le diagnostic, la gestion de la maladie et l’amélioration des résultats pour les patients souffrant de maladies gastro-intestinales (GI). Le projet créera une capsule implantable modulaire dotée d’une capacité de détection multiple pour la surveillance de la physiologie GI. Il fera appel à la communication par smartphone avec la technologie de cloud computing et des interfaces d’application pour intégrer, traiter et interpréter les données physiologiques longitudinales recueillies par la capsule. Les tests personnalisés fourniront des résultats précis à partir de l’entrée de données multi-flux dont l’interprétation sera assistée par l’IA. L’ambitieux objectif est de faciliter l’évolution des diagnostics gastro-intestinaux vers une approche de la santé en ligne centrée sur le patient et des dispositifs médicaux connectés pour le suivi à distance du patient.
Objectif
eCAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics, patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases. Our project will create a modular and implantable capsule with multi-sensing capacity that enables GI physiology monitoring for a controlled time period, leveraging the minimally invasive surgical approach of flexible endoscopy. eCAP will use a worldwide ubiquitous smartphone communication standard, together with cloud computing technology and application interfaces to integrate, process and interpret longitudinal physiological data collected by the capsule. The digital platform is designed to improve the accuracy and clinical usefulness of standard test data by incorporating patient reported outcome measures. The clinician is able to personalize the test for the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by Artificial Intelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctors worldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings using gastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluation with health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developed to train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantable capsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue version to a patient centered e-health tool and to make Europe the leader in the rapidly growing field of connected medical devices for remote patient monitoring.
Champ scientifique
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health sciencesbasic medicinephysiology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- medical and health sciencesclinical medicinegastroenterology
Mots‑clés
Programme(s)
Régime de financement
HORIZON-IA - HORIZON Innovation ActionsCoordinateur
67000 Strasbourg
France